Abilify and blood creatine phosphokinase increased 
Abilify and blood creatine phosphokinase increased Patient Reports February 11, 2012
Abilify Side Effects Report #4777541-0
Abilify side effect was reported by a Health Professional from GERMANY on Sept 12, 2005. Male patient, 30 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, hepatic steatosis, muscle spasms. Abilify dosage: unknown. During the same period patient was treated with CITALOPRAM, METOPROLOL. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4943550-1
Abilify side effect was reported by a Physician from AUSTRALIA on Dec 16, 2005. Male patient, 68 years of age, was diagnosed with schizophrenia, depression
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle atrophy, neuroleptic malignant syndrome. Abilify dosage: unknown. During the same period patient was treated with CITALOPRAM. Patient recovered.Abilify Side Effects Report #5006667-1
Abilify side effect was reported by a Physician from AUSTRALIA on Dec 16, 2005. Male patient, 68 years of age, was diagnosed with schizophrenia, depression
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle atrophy, neuroleptic malignant syndrome. Abilify dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient recovered.Abilify Side Effects Report #6057549-8
Abilify side effect was reported by a Health Professional from JAPAN on Jan 16, 2009. Male patient, 67 years of age, weighting 211.6 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, constipation
, delusion, hallucination. Abilify dosage: 6DEC-09JAN-12MG,10JAN/11JUN08-18MG;ORAL,12JUN/04JUL08-30MG,05JUL08-24MG 154 DAYS. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE, NITRAZEPAM, ETIZOLAM, VALPROATE, RISPERIDONE, LORMETAZEPAM, HALOPERIDOL, POLYCARBOPHIL CALCIUM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #6064784-1
Abilify side effect was reported by a Health Professional from JAPAN on Jan 23, 2009. Male patient, 67 years of age, weighting 211.6 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, constipation
, delusion, hallucination. Abilify dosage: 6DEC-09JAN-12MG,10JAN/11JUN08-18MG;ORAL,12JUN/04JUL08-30MG,05JUL08-ONG 24MG 154 DAYS. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE, NITRAZEPAM, ETIZOLAM, VALPROATE, RISPERIDONE, LORMETAZEPAM, HALOPERIDOL, POLYCARBOPHIL CALCIUM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5014647-5
Abilify side effect was reported by a Physician from FRANCE on Mar 06, 2006. Female patient, 64 years of age, weighting 138.9 lb, was diagnosed with schizophrenia, agitation, dissociative disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, convulsion, hyperchloraemia. Abilify dosage: 20 MG 03-MAY-05 TO 16-SEP-05; 15 MG 17-SEP-05 TO 21-FEB-06; 30 MG 21-FEB-06 TO 23-FEB-06. During the same period patient was treated with TERCIAN, LEVOTHYROX, SERESTA. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #6060635-X
Abilify side effect was reported by a Health Professional from JAPAN on Jan 22, 2009. Female patient, 63 years of age, weighting 121.3 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, anorexia, blood creatine phosphokinase increased, cardiac arrest
, cardiac failure acute, decreased appetite, depressed level of consciousness, diet refusal. Abilify dosage: 14JAN08-10FEB08:12MG/D 11FEB08-15DEC08:24MG/D. During the same period patient was treated with FLUNITRAZEPAM, ZYPREXA, SENNOSIDE A, SELOKEN, GASTER, BENZALIN, DEPAS. Patient died on 12/15/2008.Abilify Side Effects Report #5897804-5
Abilify side effect was reported by a Consumer or non-health professional from GERMANY on Sept 24, 2008. Female patient, 60 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, extrapyramidal disorder, hyperthermia, lung disorder, tachycardia. Abilify dosage: UNK-JUL-2008 - UNK-SEP-2008:20 MG UNK-SEP-2008 - UNK-SEP-2008:25 MG INITIATED WITH 20 MG. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4612534-5
Abilify side effect was reported by a Health Professional from on Mar 08, 2005. Female patient, 54 years of age, weighting 200.6 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest
, electrocardiogram st segment elevation, fall , hyperkalaemia, malaise, psychomotor hyperactivity, respiratory arrest. Abilify dosage: unknown. During the same period patient was treated with LEPTICUR, RIVOTRIL, TERCIAN, LIPANTHYL, RISPERDAL. Patient died.Abilify Side Effects Report #4626836-X
Abilify side effect was reported by a Health Professional from on Mar 08, 2005. Female patient, 54 years of age, weighting 200.6 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest
, electrocardiogram st segment elevation, fall , hyperkalaemia, malaise, psychomotor hyperactivity, respiratory arrest. Abilify dosage: unknown. During the same period patient was treated with LEPTICUR, RIVOTRIL, TERCIAN, LIPANTHYL, RISPERDAL. Patient died.Abilify Side Effects Report #4744693-8
Abilify side effect was reported by a Health Professional from FRANCE on Mar 08, 2005. Female patient, 54 years of age, weighting 200.6 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest
, electrocardiogram st segment elevation, fall , hyperkalaemia, malaise, psychomotor hyperactivity, respiratory arrest. Abilify dosage: unknown. During the same period patient was treated with LEPTICUR, CLONAZEPAM, TERCIAN, LIPANTHYL, RISPERDAL. Patient died.Abilify Side Effects Report #5204037-4
Abilify side effect was reported by a Physician from UNITED STATES on Dec 02, 2005. Female patient, 51 years of age, was diagnosed with schizophrenia, anaemia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle spasms, myalgia. Abilify dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.
Abilify Side Effects Report #5205754-2
Abilify side effect was reported by a Physician from GERMANY on Jan 04, 2007. Male patient, 51 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: agitation, blood creatine phosphokinase increased, coordination abnormal, delirium, dementia
, restlessness, salivary hypersecretion. Abilify dosage: unknown. During the same period patient was treated with LEPONEX, RISPERDAL, FURORESE. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4956304-7
Abilify side effect was reported by a Physician from GERMANY on Mar 17, 2006. Male patient, 51 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: agitation, blood creatine phosphokinase increased, coordination abnormal, delirium, restlessness, salivary hypersecretion, somnolence. Abilify dosage: unknown. During the same period patient was treated with CLOZAPINE, RISPERDAL, FURORESE. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4841200-6
Abilify side effect was reported by a Physician from UNITED STATES on Oct 27, 2005. Female patient, 50 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle spasms, myalgia. Abilify dosage: unknown. During the same period patient was treated with VITAMINS. Patient recovered.
Abilify Side Effects Report #5701863-X
Abilify side effect was reported by a Physician from SWITZERLAND on Apr 02, 2008. Female patient, 48 years of age, was diagnosed with schizophrenia, affective disorder, hiv infection
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscular weakness, myoglobin blood increased. Abilify dosage: unknown. During the same period patient was treated with REYATAZ, EFFEXOR, CONCERTA. Patient recovered.Abilify Side Effects Report #5735997-0
Abilify side effect was reported by a Physician from SWITZERLAND on May 09, 2008. Female patient, 48 years of age, was diagnosed with schizophrenia, affective disorder, hiv infection
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscular weakness, myoglobin blood increased. Abilify dosage: unknown. During the same period patient was treated with REYATAZ, LORAZEPAM, EFFEXOR, CONCERTA, TRUVADA, NORVIR, ALDACTONE. Patient recovered.Abilify Side Effects Report #6097281-8
Abilify side effect was reported by a Health Professional from JAPAN on Feb 17, 2009. Female patient, 44 years of age, weighting 185.2 lb, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, psychiatric symptom. Abilify dosage: 12MGQD 16-OCT-22OCT(7 DAYS),24MGQD 23OCT-19NOV(28 DAYS),30MGQD 20-NOV-17DEC08(28 DAYS);18NOV-ONG. During the same period patient was treated with ZYPREXA, DEPAKENE, BROTIZOLAM, PURSENNIDE, QUAZEPAM, SELENICA. Patient recovered.
Abilify Side Effects Report #4602942-0
Abilify side effect was reported by a Health Professional from on July 22, 2004. Female patient, 41 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, convulsion, hyponatraemia, loss of consciousness, muscle spasms, polydipsia, vomiting. Abilify dosage: unknown. During the same period patient was treated with CIPRAMIL, RISPERDAL, TAVOR. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4844943-3
Abilify side effect was reported by a Physician from GERMANY on July 22, 2004. Female patient, 41 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, convulsion, hyponatraemia, loss of consciousness, vomiting. Abilify dosage: unknown. During the same period patient was treated with CIPRAMIL, RISPERDAL, TAVOR, DIOVAN HCT. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #5107624-7
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2006. Female patient, 32 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: aggression, blood creatine phosphokinase increased, cardiac failure, cardio-respiratory arrest, irritability. Abilify dosage: unknown. During the same period patient was treated with FLUPHENAZINE DECANOATE, RISPERIDONE, ZOTEPINE, CARBAMAZEPINE, LORAZEPAM, BIPERIDEN HYDROCHLORIDE, BIPERIDEN HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE. Patient died on 08/17/2006.
Abilify Side Effects Report #5072521-2
Abilify side effect was reported by a Health Professional from AUSTRALIA on July 27, 2006. Female patient, 23 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, dystonia
, neuroleptic malignant syndrome, pyrexia, torticollis. Abilify dosage: unknown. During the same period patient was treated with RISPERIDONE. Patient recovered.Abilify Side Effects Report #5022197-5
Abilify side effect was reported by a Physician from FRANCE on May 03, 2006. Male patient, 22 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: anxiety
, back pain , blood creatine phosphokinase increased, catatonia, hyperhidrosis, pallor, rhabdomyolysis. Abilify dosage: unknown. During the same period patient was treated with TEMESTA, TERCIAN. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5054746-5
Abilify side effect was reported by a Physician from SPAIN on July 14, 2006. Male patient, 21 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood bilirubin abnormal, blood creatine phosphokinase increased. Abilify dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient recovered.
Abilify Side Effects Report #5120233-9
Abilify side effect was reported by a Physician from SPAIN on July 14, 2006. Male patient, 21 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood bilirubin abnormal, blood creatine phosphokinase increased. Abilify dosage: unknown. During the same period patient was treated with RIVOTRIL. Patient recovered.
Abilify Side Effects Report #5204414-1
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Male patient, 20 years of age, weighting 233.7 lb, was diagnosed with schizophrenia, bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: unknown. During the same period patient was treated with MEROPENEM, VANCOMYCIN, METRONIDAZOLE, VERSED, FENTANYL TRANSDERMAL SYSTEM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4876114-9
Abilify side effect was reported by a Physician from UNITED STATES on Jan 06, 2006. Female patient, 15 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome. Abilify dosage: 10 MGM PO. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #6040984-1
Abilify side effect was reported by a Physician from UNITED STATES on July 22, 2008. Female patient, 48 years of age, was diagnosed with schizoaffective disorder, mild mental retardation and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood pressure decreased, syncope. Abilify dosage: unknown. During the same period patient was treated with CLOZAPINE. Patient recovered.
Abilify Side Effects Report #5879891-3
Abilify side effect was reported by a Pharmacist from UNITED STATES on Sept 11, 2008. Female patient, 45 years of age, was diagnosed with schizoaffective disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: 30MG QD PO. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #5095396-4
Abilify side effect was reported by a Physician from GERMANY on Aug 23, 2006. Female patient, 42 years of age, was diagnosed with schizoaffective disorder, depressive delusion, depression
, extrapyramidal disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest , circulatory collapse, coma, dehydration, gastroenteritis , hypovolaemia, ileus paralytic. Abilify dosage: unknown. During the same period patient was treated with GLIANIMON, LAMOTRIGINE, APONAL, AKINETON. Patient was hospitalized. Patient died on 07/06/2006.Abilify Side Effects Report #5134894-1
Abilify side effect was reported by a Physician from GERMANY on July 11, 2006. Female patient, 42 years of age, was diagnosed with schizoaffective disorder, depressive delusion, impulse-control disorder, depression
, extrapyramidal disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest , circulatory collapse, coma, dehydration, gastroenteritis , hypovolaemia, ileus paralytic. Abilify dosage: DOSE INCREASED TO 10 MG DAILY ON 29-JUN-2006.. During the same period patient was treated with GLIANIMON, LAMICTAL, APONAL, AKINETON. Patient was hospitalized. Patient died on 07/06/2006.Abilify Side Effects Report #5134895-3
Abilify side effect was reported by a Physician from GERMANY on Aug 23, 2006. Female patient, 42 years of age, was diagnosed with schizoaffective disorder, depressive delusion, depression
, extrapyramidal disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac arrest , circulatory collapse, coma, dehydration, gastroenteritis , hypovolaemia, ileus paralytic. Abilify dosage: unknown. During the same period patient was treated with GLIANIMON, LAMOTRIGINE, APONAL, AKINETON. Patient was hospitalized. Patient died on 07/06/2006.Abilify Side Effects Report #5959746-6
Abilify side effect was reported by a Health Professional from SPAIN on Nov 13, 2008. Male patient, 37 years of age, was diagnosed with schizoaffective disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: abdominal pain
, blood creatine phosphokinase increased, constipation , deep vein thrombosis , nausea , pulmonary embolism , somnolence, urinary retention. Abilify dosage: 10 MG 28 TABLETS FOR 4 DAYS; 15 MG TABLET FOR 1 DAY. During the same period patient was treated with ZYPREXA, CLORAZEPATE DIPOTASSIUM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5535164-X
Abilify side effect was reported by a Physician from GERMANY on Nov 30, 2007. Male patient, weighting 198.4 lb, was diagnosed with schizoaffective disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, back pain
, blood creatine phosphokinase increased, blood uric acid abnormal, bradycardia, bronchopneumonia, cough, disturbance in attention, echocardiogram abnormal. Abilify dosage: 15 MG/DAY. During the same period patient was treated with ERGENYL CHRONO, LEPONEX, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5740126-3
Abilify side effect was reported by a Health Professional from JAPAN on May 08, 2008. Female patient, 74 years of age, weighting 116.8 lb, was diagnosed with psychotic disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, hyponatraemia, hypothyroidism, treatment noncompliance, ventricular extrasystoles. Abilify dosage: 6MG QD 10-JAN-08 TO 15-JAN-08; 18MG QD 16-JAN-08 TO 28-JAN-08.. During the same period patient was treated with NITRAZEPAM, NORVASC, THYRADIN S, LEVOMEPROMAZINE MALEATE, CORTRIL. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4837773-X
Abilify side effect was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2005. Male patient, 58 years of age, was diagnosed with psychotic disorder
, depression , salivary hypersecretion and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, mental impairment, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with OXYBUTYNIN, DULOXETINE, CLOZARIL, HYOSCINE HYT, OLANZAPINE. Patient recovered.Abilify Side Effects Report #4943556-2
Abilify side effect was reported by a Health Professional from UNITED KINGDOM on Nov 16, 2005. Male patient, 58 years of age, weighting 145.5 lb, was diagnosed with psychotic disorder
, depression , salivary hypersecretion and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, mental impairment, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with OXYBUTYNIN, DULOXETINE, CLOZARIL, HYOSCINE HYT, FLUOXETINE. Patient recovered.Abilify Side Effects Report #6040763-5
Abilify side effect was reported by a Physician from UNITED STATES on May 21, 2008. Female patient, 21 years of age, was diagnosed with psychotic disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: abasia, blood creatine phosphokinase increased, delirium, hyperhidrosis, hypotension, musculoskeletal stiffness, syncope. Abilify dosage: unknown. During the same period patient was treated with PROZAC. Patient recovered.Abilify Side Effects Report #5818877-1
Abilify side effect was reported by a Physician from ITALY on July 18, 2008. Female patient, 64 years of age, was diagnosed with psychomotor hyperactivity, schizophrenia, anxiety
and was treated with Abilify. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood creatine phosphokinase increased, blood creatinine increased, blood glucose increased, confusional state, dyspnoea, fibrin d dimer increased, myoglobin blood increased, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with HALOPERIDOL, DELORAZEPAM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4840980-3
Abilify side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2005. Male patient, 24 years of age, was diagnosed with obsessive-compulsive disorder
, psychotic disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, renal failure acute, rhabdomyolysis. Abilify dosage: unknown. During the same period patient was treated with LEXAPRO. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4841110-4
Abilify side effect was reported by a Physician from UNITED STATES on Sept 30, 2005. Female patient, 69 years of age, weighting 174.2 lb, was diagnosed with mania and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myalgia, neuroleptic malignant syndrome. Abilify dosage: INITIATED AT 5 MG DIALY AND TITRATED UP TO 15 MG DAILY. During the same period patient was treated with DEPAKOTE, ARICEPT. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4661208-3
Abilify side effect was reported by a Physician from on Apr 20, 2005. Female patient, 19 years of age, was diagnosed with mania and was treated with Abilify. After drug was administered, patient experienced the following side effects: aggression, aspartate aminotransferase increased, asthenia, bacteria urine identified, blood creatine phosphokinase increased, blood urea increased, body temperature increased, catatonia, confusional state. Abilify dosage: unknown. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4673308-2
Abilify side effect was reported by a Physician from on Apr 20, 2005. Female patient, 19 years of age, was diagnosed with mania and was treated with Abilify. After drug was administered, patient experienced the following side effects: aggression, aspartate aminotransferase increased, asthenia, bacteria urine identified, blood creatine phosphokinase increased, blood urea increased, body temperature increased, catatonia, confusional state. Abilify dosage: unknown. During the same period patient was treated with BIPERIDEN HYDROCHLORIDE, MIDAZOLAM. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4851412-3
Abilify side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 06, 2005. Female patient, 18 years of age, weighting 88.18 lb, was diagnosed with depression
, psychotic disorder , anxiety and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, catatonia, flat affect, muscle rigidity, neuroleptic malignant syndrome, pyrexia, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with HALOPERIDOL, THIAMINE, AMOXICILLIN, LIQUID NUTRITIONAL, DIAZEPAM, LORAZEPAM. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5629490-3
Abilify side effect was reported by a Pharmacist from UNITED STATES on Feb 15, 2008. Male patient, 38 years of age, weighting 187.0 lb, was diagnosed with dementia
and was treated with Abilify. After drug was administered, patient experienced the following side effects: ataxia , blood creatine phosphokinase increased, confusional state. Abilify dosage: 20MG QD PO. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #6073047-X
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 04, 2009. Male patient, 54 years of age, was diagnosed with bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood sodium increased, delirium, hyperreflexia, hyperthermia, liver function test abnormal, mental status changes, tremor, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with SEROQUEL, XANAX, LITHIUM CARBONATE, PROZAC, AMBIEN. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4698228-9
Abilify side effect was reported by a Consumer or non-health professional from on June 13, 2005. Male patient, 52 years of age, was diagnosed with bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: aggression, agitation, asthenia, blood creatine phosphokinase increased, body temperature increased, dyskinesia, fall , movement disorder . Abilify dosage: INCREASED TO 10 MG ONE TABLET ONCE A DAY AROUND APR-05.. During the same period patient was treated with LITHIUM, LAXATIVES. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4718561-1
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2005. Male patient, 52 years of age, was diagnosed with bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: aggression, agitation, asthenia, blood creatine phosphokinase increased, body temperature increased, cognitive disorder, dyskinesia, fall , movement disorder . Abilify dosage: INCREASED TO 10 MG ONE TABLET ONCE A DAY AROUND APR-05.. During the same period patient was treated with LITHIUM, LAXATIVES, ZANTAC, SURFAK. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5204176-8
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2005. Male patient, 28 years of age, was diagnosed with bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, body temperature increased, myalgia. Abilify dosage: unknown. Patient recovered.Abilify Side Effects Report #4675399-1
Abilify side effect was reported by a Physician from on Feb 17, 2005. Male patient, 20 years of age, was diagnosed with bipolar disorder
, psychotic disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, musculoskeletal stiffness, pyrexia. Abilify dosage: unknown. During the same period patient was treated with DEPAKOTE. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4755503-7
Abilify side effect was reported by a Physician from UNITED STATES on Feb 17, 2005. Male patient, 20 years of age, was diagnosed with bipolar disorder
, psychotic disorder and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, confusional state, musculoskeletal stiffness, pyrexia. Abilify dosage: unknown. During the same period patient was treated with DEPAKOTE, ATIVAN. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5204290-7
Abilify side effect was reported by a Physician from UNITED STATES on Jan 31, 2006. Male patient, 15 years of age, weighting 200.6 lb, was diagnosed with bipolar disorder
and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient recovered.Abilify Side Effects Report #6040006-2
Abilify side effect was reported by a Physician from UNITED STATES on Nov 14, 2007. Male patient, 74 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, polymyositis. Abilify dosage: unknown. Patient recovered.
Abilify Side Effects Report #4755513-X
Abilify side effect was reported by a Physician from UNITED STATES on Apr 19, 2005. Male patient, 71 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: unknown. Patient recovered.
Abilify Side Effects Report #4871677-1
Abilify side effect was reported by a Physician from AUSTRALIA on Dec 16, 2005. Male patient, 68 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle atrophy, neuroleptic malignant syndrome. Abilify dosage: unknown. Patient recovered.
Abilify Side Effects Report #6040303-0
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Female patient, 58 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, headache
, muscle rigidity, neuroleptic malignant syndrome, pyrexia. Abilify dosage: unknown. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #6043961-X
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2009. Male patient, 54 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood sodium increased, delirium, hyperreflexia, hyperthermia, liver function test abnormal, tremor, white blood cell count increased. Abilify dosage: unknown. During the same period patient was treated with SEROQUEL, XANAX, LITHIUM. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #6040986-5
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2008. Female patient, 48 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: INITIATED WITH 20MG AND INCREASED TO 30MG.. During the same period patient was treated with DEPAKOTE, CLONIDINE, LORAZEPAM. Patient recovered.
Abilify Side Effects Report #5639014-2
Abilify side effect was reported by a Physician from UNITED KINGDOM on Feb 21, 2008. Female patient, 46 years of age, weighting 191.8 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: agitation, blood creatine phosphokinase increased, hallucination, hallucination, auditory, hyperhidrosis, hypertension, liver function test abnormal, muscle spasms, myalgia. Abilify dosage: unknown. During the same period patient was treated with PAROXETINE. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #5204077-5
Abilify side effect was reported by a Physician from UNITED STATES on Nov 10, 2005. Male patient, 43 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased. Abilify dosage: unknown. During the same period patient was treated with BUSPAR, TRAZODONE. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #4555539-5
Abilify side effect was reported by a Consumer or non-health professional from on Nov 17, 2004. Male patient, 42 years of age, was diagnosed with schizophrenia and was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, disturbance in attention, hallucination, muscle rigidity, schizophrenia, social avoidant behaviour, tardive dyskinesia. Abilify dosage: INCREASED TO 30 MG/DAY AFTER ONE WEEK.. During the same period patient was treated with CLOZAPINE, QUETIAPINE. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #6040626-5
Abilify side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 22, 2008. Male patient, 36 years of age, weighting 167.6 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: unknown. During the same period patient was treated with VISTARIL. Patient recovered.
Abilify Side Effects Report #4550005-5
Abilify side effect was reported by a Consumer or non-health professional from on Nov 09, 2004. Male patient, 28 years of age, weighting 158.7 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myositis
. Abilify dosage: unknown. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4558260-2
Abilify side effect was reported by a Consumer or non-health professional from on Nov 09, 2004. Male patient, 28 years of age, weighting 158.7 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myositis
. Abilify dosage: unknown. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #4620008-0
Abilify side effect was reported by a Consumer or non-health professional from on Nov 09, 2004. Male patient, 28 years of age, weighting 158.7 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myositis
. Abilify dosage: unknown. Patient was hospitalized. Patient recovered.Abilify Side Effects Report #5002325-8
Abilify side effect was reported by a Physician from FRANCE on Apr 06, 2006. Female patient, 26 years of age, was treated with Abilify. After drug was administered, patient experienced the following side effects: back pain
, blood creatine phosphokinase increased, cardiac arrest , chills, feeling hot, lactic acidosis, malaise, metrorrhagia, multi-organ failure. Abilify dosage: unknown. During the same period patient was treated with TIAPRIDAL, SEROPLEX, IMOVANE, PRAZEPAM, MIFEPRISTONE, CYTOTEC. Patient died on 03/18/2006.Abilify Side Effects Report #4733275-X
Abilify side effect was reported by a Physician from UNITED STATES on June 23, 2005. Female patient, child 12 years of age, weighting 44.09 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle twitching, musculoskeletal stiffness, pharyngitis streptococcal, tremor. Abilify dosage: 5 MG ON 15-JUN-05, AND 17-JUN-05 (LAST DOSE); DOSE SKIPPED ON 16-JUN-05. During the same period patient was treated with RITALIN LA. Patient recovered.
Abilify Side Effects Report #5948345-8
Abilify side effect was reported by a Pharmacist from UNITED STATES on Nov 10, 2008. Male patient, weighting 229.3 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, mental status changes, muscle rigidity, neuroleptic malignant syndrome, pyrexia, tachycardia, tachypnoea. Abilify dosage: unknown. Patient was hospitalized. Patient recovered.
Abilify Side Effects Report #6041120-8
Abilify side effect was reported by a Physician from UNITED STATES on Aug 28, 2008. Male patient was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Abilify dosage: ABILIFY WAS INCREASED FROM 2MG TO 5MG. Patient recovered.
Abilify Side Effects Report #4756159-X
Abilify side effect was reported by a Pharmacist from UNITED STATES on Aug 29, 2005. Female patient, weighting 103.0 lb, was treated with Abilify. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, pyrexia, white blood cell count increased. Abilify dosage: 45 MG HS PO. Patient recovered.